Response to Comments: Urine Drug Testing

This Article (A59496) is a response to public comments on the Urine Drug Test LCD; it documents the comment period (4/27/2023–6/10/2023) but does not itself define coverage criteria, indications, limitations, documentation requirements, or frequency limits. No actionable coverage rules are present in the provided text; review of the full LCD/article is required for any specific policy criteria.